BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-980@pharmaconomics
DTSTAMP:20260707T003624Z
DTSTART;VALUE=DATE:20260930
DTEND;VALUE=DATE:20261001
SUMMARY:QURE PDUFA — AMT-130 (estimated date)
DESCRIPTION:The FDA's approval decision on AMT-130 for Huntington’s disease is due ~ Sep 30\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1590560/000110465926074853/tm2618105d1_ex99-1.htm\n\nTrack it: https://pharmaconomics.com/e/980
URL:https://pharmaconomics.com/e/980
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:QURE catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR